Dyne Therapeutics Inc

DYN · NASDAQ

Pharmaceutical Preparation Manufacturing

Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.

ESG Scores

Overall ESG

5.0

Environmental

6.6

Social

3.7

Governance

5.4

Gender Diversity

Female Directors0.125%

Female Executives0.3230769230769231%

CEO GenderMale

Market Data

Price$20.02-0.39 (-1.91%)

Market Cap$3.37B

P/E Ratio—

EPS$—

52W High$25.00

52W Low$7.38

Beta1.24